BCL2 and hepatocellular carcinoma: Recently, Beradi et al. showed that Bcl2/E1B19K-interacting protein 3 (BNIP3) promoted LD turnover, inhibiting hepatocellular carcinoma (HCC) growth by limiting the cellular pool of available PLs for cellular membranes.